Latest News

In early April 2026, Markel Group Inc. disclosed that its upcoming May 20, 2026 annual meeting would consider amendments to its Articles of Incorporation alongside shareholder proposals seeking the right for 10% owners to call special meetings and a report on plans to mitigate material environmental risks. The company’s decision to recommend voting against both the special-meeting and environmental-risk reporting proposals highlights a clear tension between management’s preferred governance...

In March 2026, Astrana Health, Inc. filed shelf registrations, including an ESOP-related shelf of up to US$120.95 million for 5,000,000 common shares, alongside a broad universal shelf covering common and preferred stock, debt securities, depositary shares, warrants, purchase contracts, units, and subscription rights. This broad financing toolkit, including employee stock ownership plan capacity and multiple capital instruments, gives Astrana additional flexibility to support future...

BlackRock Group has disclosed that, as of 7 April 2026, it no longer holds a substantial voting interest in Technology One, marking a shift in the company’s institutional shareholder base. This change in ownership concentration may prompt investors to reassess how Technology One’s register composition could influence perceptions of its liquidity and longer-term institutional support. We’ll now examine how BlackRock’s exit as a substantial holder may reshape Technology One’s investment...

Why Anheuser-Busch InBev (ENXTBR:ABI) is on investors’ radar Anheuser-Busch InBev (ENXTBR:ABI) has caught investor attention after recent share price moves, with the stock showing positive returns over the past week, month and past 3 months, alongside double digit annual revenue and net income growth. See our latest analysis for Anheuser-Busch InBev. Looking beyond the latest move, the 90 day share price return of 13.93% and year to date share price return of 18.46% suggest building momentum,...

Jefferies recently downgraded GPT Group to Hold following an annual general meeting that offered limited detail on current-year trading conditions, while management pointed to ongoing geopolitical uncertainty, persistent inflation, higher interest rates and emerging AI-related risks for real estate. This combination of reduced broker enthusiasm and a cautious management tone has sharpened investor focus on how resilient GPT’s office, retail and logistics portfolio may be under sustained...

Fox (FOXA) is in focus after announcing an integration with prediction market Kalshi. The deal will bring real-time, crowd-sourced odds into FOX News, FOX Business Network, FOX Weather, and FOX One programming. See our latest analysis for Fox. Despite an initial jump on the Kalshi news, the 1-day share price return of 2.77% decline sits against a 7-day share price return of 4.09% and a 90-day share price return of 17.18% decline. Total shareholder returns of 26% over 1 year and 89.69% over 3...

Why Rollins (ROL) is back in focus after its latest quarterly update Rollins (ROL) has moved back onto investors’ watchlists after reporting quarterly results where revenue was higher year on year, but adjusted operating income fell short of market expectations. See our latest analysis for Rollins. The earnings miss appears to have weighed on sentiment, with a 1 day share price return showing a 2.8% decline at US$54.23 and a 90 day share price return showing a 10.63% decline. However, the 5...

Renesas Electronics (TSE:6723) is in focus after confirming that its Intersil radiation hardened ICs are integrated into key avionics and safety subsystems on NASA’s recently launched Artemis II crewed lunar mission. See our latest analysis for Renesas Electronics. The Artemis II contract arrives at a time when momentum in Renesas Electronics’ shares has been picking up, with a 7 day share price return of 16.95% and a 1 year total shareholder return of 59.16% pointing to growing investor...

Vertical Aerospace announced in March 2026 that it had reached an agreement in principle for up to US$775,000,000 in new financing, including senior secured convertible notes, Series A convertible preferred shares and an equity line of credit with Mudrick Capital Management and Yorkville Advisors. This combination of sizeable, structured funding and the recent first piloted transition flight of its full-scale eVTOL aircraft under U.K. CAA oversight marks a meaningful step in aligning...

MINISO Group Holding (MNSO) has released a packed update, combining fourth quarter and full year 2025 earnings with fresh dividend details and progress on its multi quarter share buyback program. See our latest analysis for MINISO Group Holding. Despite the fresh dividend announcements and the update on its multi quarter buyback, MINISO Group Holding's 1 day share price return of 3.06% decline and 90 day share price return of 20.10% decline contrast with a 1 year total shareholder return of...

In recent days, attention on Waste Management has intensified ahead of its April 28, 2026 earnings release, as analysts highlight expectations for higher quarterly and full‑year profit and revenue alongside the company’s ongoing share repurchase program and decades-long pattern of dividend increases. This combination of anticipated profit growth, sustained capital returns, and growing interest in recycling and renewable natural gas has become a key focus for investors reassessing Waste...

Vertiv Holdings Co recently committed about US$50 million to expand its Ironton manufacturing plant and Westerville headquarters in Ohio, aiming to boost liquid cooling and chilled water system capacity for AI and high-density computing while adding hundreds of jobs through 2029. This expansion underpins Vertiv’s broader role as a critical provider of power and thermal infrastructure for AI data centers, reinforcing its ability to meet rising demand with shorter supply chains and greater...

Dividend announcement and buyback activity draw investor focus Fresenius Medical Care (XTRA:FME) recently announced an annual dividend of €1.49 per share, payable on 27 May 2026, with an ex dividend date of 22 May and record date of 25 May. Alongside the dividend details, the company is updating investors on a second tranche of its ongoing share buyback program, which recently included the repurchase of 553,500 shares. See our latest analysis for Fresenius Medical Care. Fresenius Medical...

In early April 2026, Anthropic, Genentech, IBM, Meta, Microsoft, and others launched the Shared AI License Foundation and IBM expanded its AI, quantum, and hardware collaborations, while also securing FedRAMP authorization for 11 watsonx and automation tools and settling a US$17,000,000 U.S. DEI probe. Together, these moves underline IBM’s push to position itself at the center of open, enterprise-grade AI and quantum infrastructure while addressing regulatory scrutiny. We’ll now explore how...

Array Technologies, Inc. recently disclosed that seven independent directors, including long-serving members and newer renewable-energy specialists, will not stand for re-election at the May 19, 2026 annual meeting, while also proposing to phase out its classified board structure in favor of annual director elections by 2029. This combination of significant board turnover and a move toward annual elections signals a shift in corporate governance that may recalibrate how investors assess...

On 9 April 2026, Amneal Pharmaceuticals announced it had launched bimatoprost ophthalmic solution 0.01% in multiple vial sizes, a generic equivalent to Allergan’s LUMIGAN indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. This launch adds a high-usage ophthalmic therapy with approximately US$719 million in recent U.S. annual sales to Amneal’s generics portfolio, underlining its focus on expanding access to lower-cost treatments...

In early April 2026, Mohawk Industries filed a definitive proxy statement urging shareholders to vote against John Chevedden’s proposal to replace supermajority voting thresholds with a simple majority standard in its charter and bylaws. This clash over corporate governance comes as Mohawk is already in the spotlight for mixed quarterly results, efficiency initiatives, and active capital returns. We’ll now examine how this governance dispute, alongside Mohawk’s recent restructuring...

The Federal Energy Regulatory Commission’s decision to lower allowed returns for New England transmission owners is set to trim Eversource Energy (ES) 2026 after-tax earnings, prompting updated guidance and raising fresh questions for income-focused investors. See our latest analysis for Eversource Energy. At a share price of US$69.97, Eversource’s recent 5.4% 1 month share price decline contrasts with a 3.2% 3 month share price gain and a 30.0% 1 year total shareholder return. This suggests...

Cohen & Steers recently reported preliminary assets under management of US$93.10 billion as of March 31 2026, down from US$98.40 billion a month earlier, with the decline mainly linked to market depreciation and client distributions, partly offset by net inflows. This shift in assets under management highlights how market conditions and payout decisions can affect fee-earning assets even when new client money is coming in. We’ll now explore how this recent assets-under-management decline may...

In recent weeks, Brigade Group subsidiaries BCV Developers and Brigade Hotel Ventures announced new management agreements with Hyatt for Hyatt House Bengaluru Devanahalli, slated to open in 2027, and Grand Hyatt Chennai ECR, targeted for 2029, while Hyatt Regency Niagara Falls Fallsview joined the World of Hyatt portfolio and Caption by Hyatt Chattanooga Downtown opened as the brand’s first property in the city. Taken together, these openings and signings highlight Hyatt’s push into...

Roivant Sciences recently reported that Priovant has begun enrolling patients in a seamless Phase 2b/3 trial of brepocitinib for lichen planopilaris and released past topline Phase 3 data from Immunovant’s batoclimab thyroid eye disease studies, which did not meet their primary endpoint but showed consistent safety. The update underscores Roivant’s growing late-stage immunology pipeline, led by brepocitinib’s FDA Priority Review in dermatomyositis and multiple additional indications...

In late March and early April 2026, UroGen Pharma announced publication of pivotal Phase 3 ENVISION data for bladder cancer therapy ZUSDURI and launched its “LG-UTUC Luminaries” program to recognize leaders in kidney-sparing care for rare upper tract urothelial cancer. Together, these steps highlight UroGen’s push to embed ZUSDURI’s evidence into clinical practice while deepening relationships with urologists focused on organ-preserving cancer management. Next, we’ll examine how the ENVISION...

Why Babcock & Wilcox Enterprises (BW) is in Focus Today Pomerantz LLP has opened an investigation into Babcock & Wilcox Enterprises (BW) for possible securities law violations, following a Wolfpack Research report on alleged conflicts tied to a $2.4b power generation contract. The short seller claims and legal scrutiny have drawn fresh attention to BW, prompting investors to reassess the company’s governance, risk profile, and how the stock’s recent moves compare with its underlying...

In March 2026, Geely Automobile Holdings reported unaudited group sales of 233,031 vehicles for the month and 709,358 year to date, both slightly higher than a year earlier. A new memorandum of understanding makes Volvo Cars the exclusive importer and operator of Lynk & Co in Europe, potentially giving Geely’s Lynk & Co brand broader access to European customers through Volvo’s established retail and service network. Next, we’ll examine how leveraging Volvo’s European dealer network through...